Inventor · disambiguated record
Pam Golden
Also filed as: GOLDEN PAM
9 granted patents·17 pending applications·32 citations·filing 2011–2025
87Inventor score
Files withSALIX PHARMACEUTICALS INC16SALIX PHARMACEUTICALS LTD5SELBO JON2BORTEY ENOCH1DUPONT HERBERT L1
Top patents by PatentIndex Score
26 records- 0195US11311521B2Solid dispersion forms of rifaximinSALIX PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·3 cites·6 claims
- 0295US11129817B2Solid dispersion forms of rifaximinSALIX PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·4 cites·12 claims
- 0394US11660292B2Solid dispersion forms of rifaximinSALIX PHARMACEUTICALS INC·Filed 2021·Granted May 30, 2023·3 cites·2 claims
- 0494US10874647B2Solid dispersion forms of rifaximinSALIX PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·7 cites·4 claims
- 0589US2025082616A1Solid Dispersion Forms of RifaximinSALIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0688US2025367175A1Solid Dispersion Forms of RifaximinSALIX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0784US9364467B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2015·Granted Jun 14, 2016·4 cites·8 claims
- 0884US2024100028A1Solid dispersion forms of rifaximinSALIX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0983US9737610B2Formulations of rifaximin and uses thereofSELBO JON·Filed 2014·Granted Aug 22, 2017·9 cites·15 claims
- 1074US9725466B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·1 cites·20 claims
- 1172US9035046B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2014·Granted May 19, 2015·1 cites·3 claims
- 1265US2020397904A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1361US2020276170A1Methods for retreating irritable bowel syndrome (ibs)SALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1460US2020230116A1Methods for retreating irritable bowel syndrome (ibs)SALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1558US2017105977A1Methods for retreating irritable bowel syndrome (ibs)SALIX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1655US2017333562A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 1752US2020069664A1Methods for treating infectionSALIX PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1851US2014349983A1Method for treating ulcerative colitisSALIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1949US2012077835A1Formulations of rifaximin and uses thereofSELBO JON·Filed 2011·Application pending·0 cites
- 2047US2013210852A1Methods for treating infectionDUPONT HERBERT L·Filed 2012·Application pending·0 cites
- 2143US2015132284A1Method of treating ulcerative colitisSALIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2242US2014349982A1Methods of treating ulcerative colitisSALIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2342US2017087134A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2442US2014163096A1Methods and compositions for treating hiv-associated diarrheaGOLDEN PAM·Filed 2013·Application pending·0 cites
- 2540US2013184302A1Methods for treating irritable bowel syndrome (ibs) and infectionsBORTEY ENOCH·Filed 2012·Application pending·0 cites
- 2635US10493064B2IBS microbiota and uses thereofSALIX PHARMACEUTICALS INC·Filed 2016·Granted Dec 3, 2019·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Pam Golden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →